Inspiratory muscle strength after COVID-19 severe pneumonia admitted to medical ICU: A Long term Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220302004

Enrollment

Registered

2022-03-02

Start date

2021-12-14

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post COVID-19 pneumonia infection COVID-19, pneumonia, muscle strength

Interventions

Subjects with post SAR-COV-2 (COVID-19 virus) infection who received MV or HFNC,Healthy control with no respiratory diseases.

Other,Other

Subjects with post SAR-COV-2 (COVID-19 virus) infection who received MV or HFNC,Healthy control

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. subjects with post COVID-19 pneumonia infection 2. age more than 18 years 3. received MV or HFNC

Exclusion criteria

Exclusion criteria: 1. pregnancy 2. stroke, neurological disease or bed ridden 3. Terminally ill patients

Design outcomes

Primary

Measure	Time frame
Inspiratory muscle strenght 3 times and 1, 3, and 6 month after discharge cmh2o	—

Secondary

Measure	Time frame
Quadriceps muscle strength 3 times and 1, 3, and 6 month after discharge Kilogram	—

Countries

Thailand

Contacts

Public ContactWarawut Chaiwong

Chiang Mai University

warawut.chai@cmu.ac.th66848092122

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026